TY - JOUR
T1 - Improvement of Neuroenergetics by Hypertonic Lactate Therapy in Patients with Traumatic Brain Injury Is Dependent on Baseline Cerebral Lactate/Pyruvate Ratio
AU - Quintard, Hervé
AU - Patet, Camille
AU - Zerlauth, Jean-Baptiste
AU - Suys, Tamarah
AU - Bouzat, Pierre
AU - Pellerin, Luc
AU - Meuli, Reto
AU - Magistretti, Pierre J.
AU - Oddo, Mauro
N1 - KAUST Repository Item: Exported on 2020-10-01
PY - 2015/9/30
Y1 - 2015/9/30
N2 - Energy dysfunction is associated with worse prognosis after traumatic brain injury (TBI). Recent data suggest that hypertonic sodium lactate infusion (HL) improves energy metabolism after TBI. Here, we specifically examined whether the efficacy of HL (3h infusion, 30-40 μmol/kg/min) in improving brain energetics (using cerebral microdialysis [CMD] glucose as a main therapeutic end-point) was dependent on baseline cerebral metabolic state (assessed by CMD lactate/pyruvate ratio [LPR]) and cerebral blood flow (CBF, measured with perfusion computed tomography [PCT]). Using a prospective cohort of 24 severe TBI patients, we found CMD glucose increase during HL was significant only in the subgroup of patients with elevated CMD LPR >25 (n = 13; +0.13 [95% confidence interval (CI) 0.08-0.19] mmol/L, p < 0.001; vs. +0.04 [-0.05-0.13] in those with normal LPR, p = 0.33, mixed-effects model). In contrast, CMD glucose increase was independent from baseline CBF (coefficient +0.13 [0.04-0.21] mmol/L when global CBF was
AB - Energy dysfunction is associated with worse prognosis after traumatic brain injury (TBI). Recent data suggest that hypertonic sodium lactate infusion (HL) improves energy metabolism after TBI. Here, we specifically examined whether the efficacy of HL (3h infusion, 30-40 μmol/kg/min) in improving brain energetics (using cerebral microdialysis [CMD] glucose as a main therapeutic end-point) was dependent on baseline cerebral metabolic state (assessed by CMD lactate/pyruvate ratio [LPR]) and cerebral blood flow (CBF, measured with perfusion computed tomography [PCT]). Using a prospective cohort of 24 severe TBI patients, we found CMD glucose increase during HL was significant only in the subgroup of patients with elevated CMD LPR >25 (n = 13; +0.13 [95% confidence interval (CI) 0.08-0.19] mmol/L, p < 0.001; vs. +0.04 [-0.05-0.13] in those with normal LPR, p = 0.33, mixed-effects model). In contrast, CMD glucose increase was independent from baseline CBF (coefficient +0.13 [0.04-0.21] mmol/L when global CBF was
UR - http://hdl.handle.net/10754/621433
UR - http://www.liebertpub.com/doi/10.1089/neu.2015.4057
UR - http://www.scopus.com/inward/record.url?scp=84964797279&partnerID=8YFLogxK
U2 - 10.1089/neu.2015.4057
DO - 10.1089/neu.2015.4057
M3 - Article
SN - 0897-7151
VL - 33
SP - 681
EP - 687
JO - Journal of Neurotrauma
JF - Journal of Neurotrauma
IS - 7
ER -